Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

337
of boosting the sense of feeling full and at the same time conducts overall calorie
reduction.
15.8 Challenges Associated withINU
INU, despite its numerous benets in the food and cosmetic industries, presents
several challenges that need to be addressed for optimal use. One signicant issue is
its solubility and stability in various formulations. INU can form gels or precipitates
at certain concentrations and temperatures, which can affect the texture and consis-
tency of products (Preeti etal. 2023). Kim etal. developed INU gel using either
shearing or heating-cooling methods. The minimum concentration of INU neces-
sary for gel formation increases as the heating temperature rises. When heating
temperatures exceed 80°C, partial hydrolysis of the dissolved INU molecules
occurs, leading to a decrease in the volumetric gel index (Kim etal. 2001). Thus,
determining optimum concentration is required for food products where consistent
texture is crucial, such as in beverages and dairy products.
Another challenge associated with INU is its potential to cause gastrointestinal
discomfort. INU is broken down by bacteria in the large intestine, a process that can
produce gas and lead to symptoms such as bloating, atulence, and abdominal pain.
Sensoy et al., conducted clinical research on agave INU to evaluate its gastrointes-
tinal (GI) tolerance due to its unique botanical origin and chemical structure com-
pared to other INU-type bers. This study aimed to assess GI tolerance and
utilization of 5.0 and 7.5g per day of agave INU in healthy adults (n=29) through
a randomized, double-blind, placebo-controlled crossover trial. Results showed that
there were slight increases in bloating, atulence, and rumbling frequency with both
doses of agave INU (Sensoy 2021). Abdominal pain and rumbling intensity were
marginally higher with 7.5g, while bloating and atulence intensity increased with
both doses (Holscher et al. 2014). Hence, these digestive issues are more pro-
nounced when INU is consumed in large quantities or by individuals with particu-
larly sensitive digestive systems. This gastrointestinal sensitivity limits the amount
of INU that can be added to food products and dietary supplements without causing
adverse effects.
Furthermore, there are substantial obstacles in procuring INU for use, which is
normally derived from chicory root or other plants. The complex and expensive
extraction procedure raises costs for manufacturers and customers. Ensuring a regu-
lar, high-quality, and long-term supply of INU is especially challenging because of
unpredictability in agricultural yields and environmental factors inuencing crop
output (Kardamanidis etal. 2024).
Finally, regulatory barriers can be a hindrance. Health claims regulation would
necessitate close inspection by agencies such as the FDA and EFSA to ensure accu-
rate and non-misleading statements about INU’s prebiotic characteristics and diges-
tive health benets. Safety assessments will continue to be critical, with in-depth
toxicity evaluations, allergenicity tests, and investigations into potential drug inter-
actions to ensure comprehensive safety standards for varied groups (Salminen and
15 Future Prospects inInulin Research

338
van Loveren 2012). Labeling regulations can be established or modied to offer
customers with clear and accurate information about INU’s presence, concentra-
tion, source, purity, and functional properties. Quality standards for INU production
will be crucial in removing contaminants and ensuring proper manufacturing pro-
cesses. International regulatory framework harmonization will become increasingly
crucial in facilitating global trade and ensuring uniform consumer protection.
15.9 Conclusion andFuture Prospective
To summarize, INU (INU) is a versatile polysaccharide with a long history extend-
ing back to the nineteenth century, and its discovery has led to multiple potential
applications in a variety of industries, including the food and pharmaceutical indus-
tries. Its prebiotic properties make it an important component for gut health, and its
capacity to operate as a fat replacer, sugar substitute, and texture modier increases
its usefulness in the food business. In pharmaceuticals, INU functions as an excipi-
ent and drug delivery system carrier, providing considerable benets in drug formu-
lation and delivery.
Looking ahead, future research should focus on optimizing extraction techniques
to improve efciency and sustainability. Additionally, exploring the potential of
INU derivatives and innovative drug delivery systems could unlock novel therapeu-
tic applications. Continued research into INU’s mechanisms of action and health
benets could further elucidate its therapeutic potential. Overall, the diverse proper-
ties and applications of INU make it a promising compound with extensive potential
uses across various industries, paving the way for exciting developments in
the future.
References
Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future direc-
tions. Molecules 26(19):5905
Anjuomo F etal (2019) Preparation and characterization of oxidized inulin hydrogel for con-
trolled drug delivery. Pharmaceutics 11(7):356
Anjuomo F etal (2021) Inulin and its application in drug delivery. Pharmaceuticals 14(9):855
Akram W etal (2024) Inulin: unveiling its potential as a multifaceted biopolymer in prebiotics,
drug delivery, and therapeutics. Int J Biol Macromol 259:129131
Alaei F, Hojjatoleslamy M, Hashemi Dehkordi SM (2018) The effect of inulin as a fat substitute on
the physicochemical and sensory properties of chicken sausages. Food Sci Nutr 6(2):512–519
Amara AAAF (2022) Natural polymer types and applications. Biomolecules from natural sources:
advances and applications, pp31–81
Anderson-Dekkers I etal (2021) Inulin. In: Handbook of hydrocolloids. Elsevier, pp537–562
Aravind SM etal (2021) Role of dietary polyphenols on gut microbiota, their metabolites and
health benets. Food Res Int 142:110189
Ayala-Fuentes JC etal (2022) Optimization of the synthesis of natural polymeric nanoparticles of
inulin loaded with quercetin: characterization and cytotoxicity effect. Pharmaceutics 14(5):888
Bao T etal (2020) Inulin exerts benecial effects on non-alcoholic fatty liver disease via modulat-
ing gut microbiome and suppressing the lipopolysaccharide-toll-like receptor 4-mψ-nuclear
A. K. Lunawat et al.

339
factor-κb-nod-like receptor protein 3 pathway via gut-liver axis in mice. Front Pharmacol
11:558525
Baral KC et al (2021) Advancements in the pharmaceutical applications of probiotics: dosage
forms and formulation technology. Int J Nanomedicine Volume 16:7535–7556
Bavaro AR etal (2024) Potential prebiotic effect of inulin-enriched pasta after invitro gastrointes-
tinal digestion and simulated gut fermentation. Food Secur 13(12):1815
Boeckner LS, Schnepf MI, Tungland BC (2001) Inulin: a review of nutritional and health
implications
Bugaj AM (2015) Intradermal delivery of active cosmeceutical ingredients. Novel delivery sys-
tems for transdermal and intradermal drug delivery. p1
Cavallaro G etal (2021) Development of new targeted inulin complex nanoaggregates for siRNA
delivery in antitumor therapy. Molecules 26(6):1713
Chadha S etal (2020) Inulin as a delivery vehicle for targeting colon-specic cancer. Curr Drug
Deliv 17(8):651–674
Chatzimitakos T etal (2023) Pulsed electric eld applications for the extraction of bioactive com-
pounds from food waste and by-products: a critical review. Biomass 3(4):367–401
Coudray C etal (2005a) Dietary inulin intake and age can signicantly affect intestinal absorption
of calcium and magnesium in rats: a stable isotope approach. Nutr J 4(1):29
Coudray C etal (2005b) Stimulatory effect of inulin on intestinal absorption of calcium and mag-
nesium in rats is modulated by dietary calcium intakes: short–and long–term balance studies.
Eur J Nutr 44:293–302
da Silva Figueira OA (2020) Prole analysis of oligosaccharides in Yacon (Smallanthus sonchifo-
lius) roots: extraction optimization and inulin hydrolysis. Universidade da Madeira (Portugal)
Du Y etal (2024) Protective effects of inulin on stress-recurrent inammatory bowel disease. Int
J Mol Sci 25(5):2494
Fares MM, Khanfar M (2011) Inulin and poly (acrylic acid) grafted inulin for dissolution enhance-
ment and preliminary controlled release of poorly water-soluble Irbesartan drug. Int J Pharm
410(1–2):206–211
Ghali ENHK, Chauhan SC, Yallapu MM (2024) Inulin-based formulations as an emerging thera-
peutic strategy for cancer: a comprehensive review. Int J Biol Macromol 259:129216
Giri S, Dutta P, Giri TK (2021) Inulin-based carriers for colon drug targeting. J Drug Deliv Sci
Technol 64:102595
Gupta N etal (2019) Inulin: a novel and stretchy polysaccharide tool for biomedical and nutritional
applications. Int J Biol Macromol 132:852–863
Han L etal (2022) Octenyl-succinylated inulins for the delivery of hydrophobic drug. Int J Biol
Macromol 221:1112–1120
Hancı F (2023) A plant: seen by many, known by few: Jerusalem artıchoke (Helianthus tuberosus L.)
Hendrysiak A etal (2023) Juice powders from rosehip (Rosa canina L.): physical, chemical, and
antiglycation properties. Molecules 28(4):1674
Hinrichs W etal (2005) Inulin is a promising cryo-and lyoprotectant for PEGylated lipoplexes. J
Control Release 103(2):465–479
Holscher HD et al (2014) Gastrointestinal tolerance and utilization of agave inulin by healthy
adults. Food Funct 5(6):1142–1149
Honda-Okubo Y, Saade F, Petrovsky N (2012) Advax™, a polysaccharide adjuvant derived from
delta inulin, provides improved inuenza vaccine protection through broad-based enhancement
of adaptive immune responses. Vaccine 30(36):5373–5381
Hou Y etal (2022) Targeted therapeutic effects of oral inulin-modied double-layered nanopar-
ticles containing chemotherapeutics on orthotopic colon cancer. Biomaterials 283:121440
Hussein LA (2022) Novel prebiotics and next-generation probiotics: opportunities and challenges.
Functional foods and nutraceuticals in metabolic and non-communicable diseases, pp431–457
Hutchinson NT (2023) Effects of the gut microbiota and dietary inulin on age associated inam-
mation, endurance training adaptations, and voluntary wheel running motivation. University of
Illinois at Urbana-Champaign
Igoe RS (2011) Dictionary of food ingredients. Springer
15 Future Prospects inInulin Research

340
Illippangama AU etal (2022) Inulin as a functional ingredient and their applications in meat prod-
ucts. Carbohydr Polym 275:118706
Jangid AK etal (2024) Engineered inulin-based hybrid biomaterials for augmented immunomodu-
latory responses. Carbohydr Polym 340:122311
Joseph S et al (2024) Synthesis, characterization, and application of honey stabilized inulin
nanoparticles as colon targeting drug delivery carrier. Int J Biol Macromol 263:130274
Kamel DG et al (2021) Addition of inulin to probiotic yogurt: viability of probiotic bacteria
(Bidobacterium bidum) and sensory characteristics. Food Sci Nutr 9(3):1743–1749
Kardamanidis A, etal (2024) Inulin production from chicory roots—process modeling and techno-
economic assessment (TEA) using SuperPro designer.
Kermanian M etal (2021) Inulin-coated iron oxide nanoparticles: a theranostic platform for con-
trast-enhanced MR imaging of acute hepatic failure. ACS Biomater Sci Eng 7(6):2701–2715
Kesharwani SS etal (2019) Hydrophobically modied inulin-based micelles: transport mecha-
nisms and drug delivery applications for breast cancer. J Drug Deliv Sci Technol 54:101254
Kim Y, Faqih M, Wang S (2001) Factors affecting gel formation of inulin. Carbohydr Polym
46(2):135–145
Kumar S etal (2016) Discovery of inulin acetate as a novel immune-active polymer and vaccine
adjuvant: synthesis, material characterization, and biological evaluation as a toll-like recep-
tor-4 agonist. J Mater Chem B 4(48):7950–7960
Kumar S et al (2017) Pathogen-mimicking vaccine delivery system designed with a bioactive
polymer (inulin acetate) for robust humoral and cellular immune responses. J Control Release
261:263–274
Licciardi M etal (2016) Preparation and characterization of inulin coated gold nanoparticles for
selective delivery of doxorubicin to breast cancer cells. J Nanomater 2016(1):2078315
Lombardo R etal (2021) Nanotechnologies for intranasal drug delivery: an update of literature.
Pharm Dev Technol 26(8):824–845
Madani F etal (2020) An overview on dosage forms and formulation strategies for vaccines and
antibodies oral delivery. Pharm Dev Technol 25(2):133–148
Meola TR etal (2024) Inulin-lipid core–shell microcapsules target the gut microbiota and mimic the
pharmaceutical food effect for improved oral antipsychotic delivery. Adv Funct Mater:2403914
Mishra D, Hubenak JR, Mathur AB (2013) Nanoparticle systems as tools to improve drug delivery
and therapeutic efcacy. J Biomed Mater Res Part A 101(12):3646–3660
Najwa MH, Solehah NN (2020) Encapsulation of protein within alginate-inulin matrix for targeted
drug delivery system. J Phys Conf Ser 1532(1):012013
Okafor NI (2022) Investigation of suitable microencapsulation techniques in the preformulation of
selected antiretroviral drugs. University of the Western Cape
Panwar D, Panesar PS, Saini A (2022) Prebiotics and their role in functional food product devel-
opment. Probiotics, prebiotics and synbiotics: technological advancements towards safety and
industrial applications, pp233–271
Paseephol T (2008) Characterisation of prebiotic compounds from plant sources and food indus-
try wastes: inulin from Jerusalem artichoke and lactulose from milk concentration permeate.
RMIT University
Petkova N, Sherova G, Denev P (2018) Characterization of inulin from dahlia tubers isolated by
microwave and ultrasound-assisted extractions. Int Food Res J 25(5):876–1884
Petrova P, Petrov K (2017) Prebiotic–probiotic relationship: the genetic fundamentals of poly-
saccharides conversion by Bidobacterium and lactobacillus genera. In: Food bioconversion.
Elsevier, pp237–278
Preeti etal (2023) Nanoemulsion: an emerging novel technology for improving the bioavailability
of drugs. Scientica (Cairo) 2023:6640103
Rodríguez-García J, Salvador A, Hernando I (2014) Replacing fat and sugar with inulin in cakes:
bubble size distribution, physical and sensory properties. Food Bioprocess Technol 7:964–974
Salminen S, van Loveren H (2012) Probiotics and prebiotics: health claim substantiation. Microb
Ecol Health Dis 23. https://doi.org/10.3402/mehd.v23i0.18568
A. K. Lunawat et al.

341
Sensoy I (2021) A review on the food digestion in the digestive tract and the used invitro models.
Curr Res Food Sci 4:308–319
Shi F etal (2023) Preliminary exploration of inulin and inulin liposome on DSS-induced colitis
remission. J Drug Deliv Sci Technol 88:104911
Signoret C, Jacobs H (2014) Chicory fructans in nutrition and the formulation of foods dedicated
to blood glucose disorder management, in polysaccharides. CRC Press, pp278–319
Thakkar S, etal (2016) Excipients and their functionality for enabling technologies in oral dosage
forms. Pharmaceutical excipients: properties, functionality, and applications in research and
industry, pp97–143
Tripodo G, Mandracchia D (2019) Inulin as a multifaceted (active) substance and its chemical
functionalization: from plant extraction to applications in pharmacy, cosmetics and food. Eur
J Pharm Biopharm 141:21–36
Tripodo G etal (2019) Drug delivery of rifampicin by natural micelles based on inulin: physi-
cochemical properties, antibacterial activity and human macrophages uptake. Eur J Pharm
Biopharm 136:250–258
Ullah F etal (2015) Classication, processing and application of hydrogels: a review. Mater Sci
Eng C 57:414–433
Usman M etal (2021) Potential applications of hydrophobically modied inulin as an active ingre-
dient in functional foods and drugs—A review. Carbohydr Polym 252:117176
Van Loo J, Bosscher D (2008) Inulin-type fructans. Therapeutic microbiology: probiotics and
related strategies, pp147–157
Vatansever O et al (2023) Coating with cationic inulin enhances the drug release prole and
invitro anticancer activity of lecithin-based nano drug delivery systems. Int J Biol Macromol
237:123955
Verma DK etal (2021) A review of the composition and toxicology of fructans, and their applica-
tions in foods and health. J Food Compos Anal 99:103884
Wei Q etal (2023) Immunologically effective biomaterials-enhanced vaccines against infection of
pathogenic microorganisms. Biosafety Health 5(01):45–61
Xue M, Wang J, Huang M (2022) Inulin-modied liposomes as a novel delivery system for cin-
namaldehyde. Food Secur 11(10):1467
Zhang L et al (2014) Synthesis of methylprednisolone loaded ibuprofen modied inulin based
nanoparticles and their application for drug delivery. Mater Sci Eng C 42:111–115
Zhang Q etal (2018a) Inulin-type fructan improves diabetic phenotype and gut microbiota proles
in rats. PeerJ 6:e4446
Zhang X etal (2018b) Pharmaceutical dispersion techniques for dissolution and bioavailability
enhancement of poorly water-soluble drugs. Pharmaceutics 10(3):74
Zhu Z etal (2016) Recent insights for the green recovery of inulin from plant food materials using
non-conventional extraction technologies: a review. Innovative Food Sci Emerg Technol 33:1–9
15 Future Prospects inInulin Research


343
16
Potential ofInulin toRevolutionize
Pharmaceutical Industries
PrathapMadeswaraGuptha, T.Deepan, V.Alekkhya,
RaghavendraKumarGunda, MolakpoguRavindraBabu,
andSagarPamu
Abstract
Inulin is a naturally occurring polysaccharide composed of fructose units linked
by beta-2 glycoside bonds. It has been recently converted from a dietary ber to
an agent and revolution in pharmaceutical sciences. Due to its resistance to
digestion in the upper gastrointestinal tract and unique chemical properties, inu-
lin makes it an emerging versatile component used in advanced drug delivery
systems. The overview of the possible applications of inulin in modern medicine
is also discussed in relation to its uses in controlled-release tablets, injectable
microparticles, and mucosal delivery systems and, lastly, in liposomes. The pre-
biotic effects of inulin, its low energy density, and the enhancement of drug solu-
bility and bioavailability are of high interest in the management of several
diseases, including diabetes, obesity, and gut health. Controlled-release systems
achieve gradual delivery; nanoparticle and hydrogel delivery provide opportuni-
ties for targeted delivery and good patient compliance. Other applications relate
P. M. Guptha
Department of Pharmaceutical Sciences, Vignan’s Foundation for Science, Technology and
Research (Deemed to be University), Guntur, Andhra Pradesh, India
T. Deepan · V. Alekkhya
GIET School of Pharmacy, Rajahmundry, Andhra Pradesh, India
R. K. Gunda
Department of Pharmaceutics, Narasaraopeta Institute of Pharmaceutical Sciences,
Narasaraopet, Andhra Pradesh, India
M. R. Babu
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University,
Greater Noida, Uttar Pradesh, India
S. Pamu (*)
Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior,
Madhya Pradesh, India

344
to mucosal delivery systems and liposomes, which enhance stability and drug
release. Though it is very promising in nature, challenges persist in terms of its
inherent sweetness in nonsweet applications and the need for cost-effective
solutions for their manufacture. The effectiveness of inulin in targeted cancer
therapy and personalized medicine is still being evaluated through ongoing
research and clinical studies, thus underlining its potential capability with
advanced drug delivery technologies. Emerging developments and future views
on inulin-based drug delivery systems highlight its contribution to enhancing
treatment strategies and patient outcomes via new and synergistic methods. Due
to its natural biodegradability, exibility, and adaptability, inulin may contribute
signicantly to shaping pharmaceutical progress.
Keywords
Inulin · Prebiotic effects · Liposomes · Bioavailability · Cancer therapy
16.1 Introduction
Inulin, a naturally occurring carbohydrate, has changed a lot. It used to be an impor-
tant part of plants but could now be a drug wonder. Before it was only used as food
ber, inulin’s unique qualities and health benets got a lot of research attention,
which put it at the center of modern medicine (Wong etal. 2017). Because this ex-
ible fructan has many benets, it could be used in many drugs and health products.
Inulin used to only be found in food ber, but now its unique properties and health
benets have gotten a lot of scientic attention, putting it at the heart of modern
medicine. Changing the three hydroxyl groups on each fructose unit can make it
more soluble, help drugs and proteins work better, and control how long they stay
in the body. The unique structure of inulin is built with different fructose units that
are joined together using beta-2 glycoside bonds. It can go through the upper diges-
tive system without being broken down because of how it is built. Because of this
link, inulin cannot be broken down by the stomach enzymes that people make. It is
not the same as starches or simple sugars made from glucose because of this (Wong
etal. 2017).
The pharmaceutical business is interested in inulin because it has some unique
properties. Because of this, experts are looking into whether it could be used to help
different illnesses. It is a good idea to make custom drug delivery ways with inulin-
based therapy (Akram etal. 2019). Inulin protects healthy cells by enclosing tiny
chemicals and sends drugs directly to tissues that are harmed. New medicines are
being made to help people with gut difculties like irritable bowel syndrome (IBS)
plus inammatory bowel disease (IBD) with the help of inulin’s prebiotic qualities
(Bărboi etal. 2020). Inulin has been shown to help good bacteria grow. This may
help keep the germs in the gut in balance and make many diseases easier to deal with.
Recent research examines the potential of using inulin’s immune-regulating
properties to treat autoimmune conditions including multiple sclerosis and rheuma-
toid arthritis. Inulin is generally thought to be safe in small amounts, but some
P. M. Guptha et al.

345
people may experience gut pain, such as gas, bloating, and cramps, after adding it
to their diet. To allow the gut bacteria time to change, it is best to slowly increase the
amount of inulin you eat.
16.1.1 Inulin into aPotent Medicinal Agent
Extended glucose metabolism produces fructan of the inulin-type, fructose-based
polymers soluble in water. Often, plants store carbohydrates in their leaves and
other organs. Currently, inulin is called a “pharmaceutical powerhouse” due to its
multifaceted role as a medicinal agent and dietary ber with several uses (Wang and
Cheong 2023). Still, the tale of inulin’s ascent to fame goes beyond its nutritional
signicance. Soon after, scientists discovered that it has medicinal potential and
nutritional benets. According to studies, inulin has unique physicochemical quali-
ties that make it a desirable option for use in pharmaceuticals. Its biocompatibility,
biodegradability, and capacity to form gels, microspheres, and nanoparticles made
numerous medical applications possible. Insulin has several important uses, one of
which is in medication delivery systems (Akram etal. 2024). Because of its adapt-
ability, it allows a wide range of therapeutic agents—from small compounds to
biologics—to be encapsulated and released under regulated conditions. By develop-
ing formulations targeted for certain tissues or cells, improving bioavailability, and
encasing drugs inside inulin-based carriers, researchers have transformed drug
delivery techniques. The pharmaceutical sector is beginning to recognize the poten-
tial of insulin. Numerous medications may become more effective and bioavailable
with the rise of inulin-based drug delivery systems. Because inulin’s sustained-
release characteristics provide for regulated and progressive medication administra-
tion, less pharmaceutical side effects and better patient compliance may follow
(Mensink etal. 2015a).
Inulin has advantages beyond digestion. Studies suggest it regulates the immune
system, preventing allergies and inammatory bowel diseases. Research is also
looking at insulin’s weight control function. It supports weight reduction initiatives
by regulating blood sugar and promoting satiety (Moser etal. 2015; Qin etal. 2023).
Inulin’s pharmaceutical product development is early. Investigations into its numer-
ous uses are underway. In addition to immunotherapy and medication delivery, inu-
lin has various medicinal uses. Changing gut microbiota may affect cancer formation
and progression, making it a promising cancer therapy (Moser etal. 2015). Ongoing
research on its function in enhancing calcium absorption may help prevent and cure
osteoporosis. Inulin may also regulate cholesterol and blood sugar to control meta-
bolic syndrome, offering a multimodal approach to complicated health conditions.
16.1.2 Properties andPotential Applications
Because of its numerous useful characteristics, inulin is a chemical that might nd
use in a wide range of industries. This soluble ber from plants is a great prebiotic
16 Potential ofInulin toRevolutionize Pharmaceutical Industries

346
because it helps good bacteria thrive in the stomach and maintains healthy digestion
(Kim etal. 2001). Due to its low glycemic index, it may be used as a sugar substitute
in recipes without negatively impacting those with diabetes. Pharmaceutical compa-
nies also use inulin for glomerular ltration rate (GFR) testing because it is biocom-
patible, which means it will not hurt the patient, and because it has the potential to
increase the permeability and retention of medications (Carboni etal. 2022). Inulin
has many practical applications in nutrition, medicine, and the area of materials sci-
ence due to its unique combination of characteristics. As an illustration of how this
component is revolutionizing this industry, consider biodegradable polymers,
encapsulating systems, and controlled-release formulations (Riva etal. 2023).
16.1.3 Innovative Drug Delivery Systems
Synthetic polymers have long dominated regulated medication delivery. However,
their instability, high modication costs, fragile structural integrity, and limited tar-
geting capability have led to a move towards natural alternatives. Due to their inher-
ent properties, natural polysaccharides may be used in effective drug delivery
systems. They target specic cells and are biocompatible and biodegradable, unlike
synthetic ones. Inulin, an abundant polysaccharide found in chicory, artichokes,
fruits, and grains, is notable for its unique properties (Sheng etal. 2023). Its exibil-
ity, self-assembly, and protein stabilization make it ideal for drug delivery scaffolds
and biomaterials (Kim etal. 2001). Due to its chemical plasticity, inulin may be
changed to optimize medicine delivery to genetic material or cancer cells (Jackson
etal. 2023). This is conceivable because inulin is versatile. Its fructose units have
several hydroxyl groups, making functional agent linking easier. The switch from
synthetic polymers to natural polysaccharides like inulin allows for effective, biode-
gradable, inexpensive, and customizable drug delivery methods (Dehghan et al.
2013). Inulin works effectively for medicine distribution.
Many researchers employ inulin as a drug delivery agent due to its water solubil-
ity, low breaking susceptibility, and intestinal and stomach enzyme resistance. For
oral drug delivery, inulin is preferable because it delivers drugs to the colon for
maximum impact (Moser etal. 2015). Scientists protect the drug from the stomach
and upper gastrointestinal tract’s acidic conditions when taken orally. In the colon,
bidobacteria, gram-positive, non-motile, anaerobic endosymbiotic bacteria help
digest inulin (Qin etal. 2023). Because of its resilience to stomach acid, it carries
sensitive drugs and guards the walls of the stomach from nonsteroidal anti-
inammatory drugs. As a cryoprotectant and immunization adjuvant, insulin is safe
for intramuscular injection. It preserves inuenza virosomes with structural integ-
rity and fusogenic activity, indicating vaccine or other therapeutic uses (Kim etal.
2001). Inulin, a benign and nontoxic drug, has long been used intravenously to
measure GFR.A research compares intravenous and subcutaneous inulin delivery
with polyethene glycol (PEG). Due to its tiny molecular size and lengthy circulation
period, subcutaneous inulin increases permeability and retention.
P. M. Guptha et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
